Despite COVID-19, DTC Genetic Testing Market to Be Worth $1.9B by 2026
A new report from Global Industry Analysts Inc. predicts that the global market for direct-to-consumer (DTC) genetic testing will be worth $1.9 billion US by 2026. What Is Driving the Growth of the Genetic Testing Market? The report highlights several factors driving...Feds Target Fraudulent Billing of Genetic Cancer Tests
False ordering and billing of cancer genetic (CGx) tests has become a favorite target for federal fraud enforcers, with the U.S. Department of Justice (DOJ) reporting two notable convictions in the closing months of 2021. On Nov. 17, a 57-year-old former lab sales rep...Illumina Partners for Development of Next-Gen Sequencing Tests
...
Federal Enforcers Crack Down on Fraudulent Billing of Genetic Tests
Labs that bill federal health care programs for these tests need to pay especially close attention to ensure compliance.